Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Community Acquired Pneumonia (CAP) Market Size Growth Rate by Type (2014-2025) 1.4.2 Chest X-ray/Radiography 1.4.3 Sputum Gram Stain and/or Culture 1.4.4 Blood Cultures 1.5 Market by Application 1.5.1 Global Community Acquired Pneumonia (CAP) Market Share by Application (2014-2025) 1.5.2 Hospitals and Clinics 1.5.3 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Community Acquired Pneumonia (CAP) Market Size 2.2 Community Acquired Pneumonia (CAP) Growth Trends by Regions 2.2.1 Community Acquired Pneumonia (CAP) Market Size by Regions (2014-2025) 2.2.2 Community Acquired Pneumonia (CAP) Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Community Acquired Pneumonia (CAP) Market Size by Manufacturers 3.1.1 Global Community Acquired Pneumonia (CAP) Revenue by Manufacturers (2014-2019) 3.1.2 Global Community Acquired Pneumonia (CAP) Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Community Acquired Pneumonia (CAP) Market Concentration Ratio (CR5 and HHI) 3.2 Community Acquired Pneumonia (CAP) Key Players Head office and Area Served 3.3 Key Players Community Acquired Pneumonia (CAP) Product/Solution/Service 3.4 Date of Enter into Community Acquired Pneumonia (CAP) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) 4.2 Global Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) 5 United States 5.1 United States Community Acquired Pneumonia (CAP) Market Size (2014-2019) 5.2 Community Acquired Pneumonia (CAP) Key Players in United States 5.3 United States Community Acquired Pneumonia (CAP) Market Size by Type 5.4 United States Community Acquired Pneumonia (CAP) Market Size by Application 6 Europe 6.1 Europe Community Acquired Pneumonia (CAP) Market Size (2014-2019) 6.2 Community Acquired Pneumonia (CAP) Key Players in Europe 6.3 Europe Community Acquired Pneumonia (CAP) Market Size by Type 6.4 Europe Community Acquired Pneumonia (CAP) Market Size by Application 7 China 7.1 China Community Acquired Pneumonia (CAP) Market Size (2014-2019) 7.2 Community Acquired Pneumonia (CAP) Key Players in China 7.3 China Community Acquired Pneumonia (CAP) Market Size by Type 7.4 China Community Acquired Pneumonia (CAP) Market Size by Application 8 Japan 8.1 Japan Community Acquired Pneumonia (CAP) Market Size (2014-2019) 8.2 Community Acquired Pneumonia (CAP) Key Players in Japan 8.3 Japan Community Acquired Pneumonia (CAP) Market Size by Type 8.4 Japan Community Acquired Pneumonia (CAP) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Community Acquired Pneumonia (CAP) Market Size (2014-2019) 9.2 Community Acquired Pneumonia (CAP) Key Players in Southeast Asia 9.3 Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Type 9.4 Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Application 10 India 10.1 India Community Acquired Pneumonia (CAP) Market Size (2014-2019) 10.2 Community Acquired Pneumonia (CAP) Key Players in India 10.3 India Community Acquired Pneumonia (CAP) Market Size by Type 10.4 India Community Acquired Pneumonia (CAP) Market Size by Application 11 Central & South America 11.1 Central & South America Community Acquired Pneumonia (CAP) Market Size (2014-2019) 11.2 Community Acquired Pneumonia (CAP) Key Players in Central & South America 11.3 Central & South America Community Acquired Pneumonia (CAP) Market Size by Type 11.4 Central & South America Community Acquired Pneumonia (CAP) Market Size by Application 12 International Players Profiles 12.1 Pfizer 12.1.1 Pfizer Company Details 12.1.2 Company Description and Business Overview 12.1.3 Community Acquired Pneumonia (CAP) Introduction 12.1.4 Pfizer Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.1.5 Pfizer Recent Development 12.2 Astrazeneca 12.2.1 Astrazeneca Company Details 12.2.2 Company Description and Business Overview 12.2.3 Community Acquired Pneumonia (CAP) Introduction 12.2.4 Astrazeneca Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.2.5 Astrazeneca Recent Development 12.3 Bioaegis Therapeutics 12.3.1 Bioaegis Therapeutics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Community Acquired Pneumonia (CAP) Introduction 12.3.4 Bioaegis Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.3.5 Bioaegis Therapeutics Recent Development 12.4 Biotest 12.4.1 Biotest Company Details 12.4.2 Company Description and Business Overview 12.4.3 Community Acquired Pneumonia (CAP) Introduction 12.4.4 Biotest Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.4.5 Biotest Recent Development 12.5 C10 Pharma 12.5.1 C10 Pharma Company Details 12.5.2 Company Description and Business Overview 12.5.3 Community Acquired Pneumonia (CAP) Introduction 12.5.4 C10 Pharma Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.5.5 C10 Pharma Recent Development 12.6 Kyorin Pharmaceutical 12.6.1 Kyorin Pharmaceutical Company Details 12.6.2 Company Description and Business Overview 12.6.3 Community Acquired Pneumonia (CAP) Introduction 12.6.4 Kyorin Pharmaceutical Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.6.5 Kyorin Pharmaceutical Recent Development 12.7 Melinta Therapeutics 12.7.1 Melinta Therapeutics Company Details 12.7.2 Company Description and Business Overview 12.7.3 Community Acquired Pneumonia (CAP) Introduction 12.7.4 Melinta Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.7.5 Melinta Therapeutics Recent Development 12.8 Merck 12.8.1 Merck Company Details 12.8.2 Company Description and Business Overview 12.8.3 Community Acquired Pneumonia (CAP) Introduction 12.8.4 Merck Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.8.5 Merck Recent Development 12.9 Nabriva Therapeutics 12.9.1 Nabriva Therapeutics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Community Acquired Pneumonia (CAP) Introduction 12.9.4 Nabriva Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.9.5 Nabriva Therapeutics Recent Development 12.10 Paratek Pharmaceuticals 12.10.1 Paratek Pharmaceuticals Company Details 12.10.2 Company Description and Business Overview 12.10.3 Community Acquired Pneumonia (CAP) Introduction 12.10.4 Paratek Pharmaceuticals Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) 12.10.5 Paratek Pharmaceuticals Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Community Acquired Pneumonia (CAP) Key Market Segments Table Key Players Community Acquired Pneumonia (CAP) Covered Table Global Community Acquired Pneumonia (CAP) Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Community Acquired Pneumonia (CAP) Market Size Market Share by Type 2014-2025 Figure Chest X-ray/Radiography Figures Table Key Players of Chest X-ray/Radiography Figure Sputum Gram Stain and/or Culture Figures Table Key Players of Sputum Gram Stain and/or Culture Figure Blood Cultures Figures Table Key Players of Blood Cultures Table Global Community Acquired Pneumonia (CAP) Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals and Clinics Case Studies Figure Others Case Studies Figure Community Acquired Pneumonia (CAP) Report Years Considered Table Global Community Acquired Pneumonia (CAP) Market Size 2014-2025 (Million US$) Figure Global Community Acquired Pneumonia (CAP) Market Size and Growth Rate 2014-2025 (Million US$) Table Global Community Acquired Pneumonia (CAP) Market Size by Regions 2014-2025 (Million US$) Table Global Community Acquired Pneumonia (CAP) Market Size by Regions 2014-2019 (Million US$) Table Global Community Acquired Pneumonia (CAP) Market Share by Regions 2014-2019 Figure Global Community Acquired Pneumonia (CAP) Market Share by Regions 2014-2019 Figure Global Community Acquired Pneumonia (CAP) Market Share by Regions 2019 Table Market Top Trends Table Global Community Acquired Pneumonia (CAP) Revenue by Manufacturers (2014-2019) (Million US$) Table Global Community Acquired Pneumonia (CAP) Market Share by Manufacturers (2014-2019) Figure Global Community Acquired Pneumonia (CAP) Market Share by Manufacturers in 2018 Table Global Community Acquired Pneumonia (CAP) Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Community Acquired Pneumonia (CAP) Product/Solution/Service Table Date of Enter into Community Acquired Pneumonia (CAP) Market Table Mergers & Acquisitions, Expansion Plans Table Global Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table Global Community Acquired Pneumonia (CAP) Market Size Share by Type (2014-2019) Figure Global Community Acquired Pneumonia (CAP) Market Size Market Share by Type (2014-2019) Table Global Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table Global Community Acquired Pneumonia (CAP) Market Size Share by Application (2014-2019) Figure Global Community Acquired Pneumonia (CAP) Market Size Market Share by Application (2014-2019) Figure Global Community Acquired Pneumonia (CAP) Revenue Market Share by Application in 2018 Figure United States Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table United States Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table United States Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table United States Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table United States Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table United States Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table United States Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Figure Europe Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table Europe Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table Europe Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table Europe Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table Europe Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table Europe Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table Europe Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Figure China Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table China Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table China Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table China Community Acquired Pneumonia (CAP) Market Size by Type (2014-20189) (Million US$) Table China Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table China Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table China Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Figure Japan Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table Japan Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table Japan Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table Japan Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table Japan Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table Japan Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table Japan Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Figure Southeast Asia Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table Southeast Asia Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Figure India Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table India Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table India Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table India Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table India Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table India Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table India Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Figure Central & South America Community Acquired Pneumonia (CAP) Market Size 2014-2019 (Million US$) Table Central & South America Key Players Community Acquired Pneumonia (CAP) Revenue (2018-2019) (Million US$) Table Central & South America Key Players Community Acquired Pneumonia (CAP) Market Share (2018-2019) Table Central & South America Community Acquired Pneumonia (CAP) Market Size by Type (2014-2019) (Million US$) Table Central & South America Community Acquired Pneumonia (CAP) Market Share by Type (2014-2019) Table Central & South America Community Acquired Pneumonia (CAP) Market Size by Application (2014-2019) (Million US$) Table Central & South America Community Acquired Pneumonia (CAP) Market Share by Application (2014-2019) Table Pfizer Company Details Table Pfizer Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019) (Million US$) Figure Pfizer Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Pfizer Recent Development Table Astrazeneca Company Details Table Astrazeneca Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Astrazeneca Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Astrazeneca Recent Development Table Bioaegis Therapeutics Company Details Table Bioaegis Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Bioaegis Therapeutics Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Bioaegis Therapeutics Recent Development Table Biotest Company Details Table Biotest Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Biotest Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Biotest Recent Development Table C10 Pharma Company Details Table C10 Pharma Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure C10 Pharma Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table C10 Pharma Recent Development Table Kyorin Pharmaceutical Company Details Table Kyorin Pharmaceutical Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Kyorin Pharmaceutical Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Kyorin Pharmaceutical Recent Development Table Melinta Therapeutics Company Details Table Melinta Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Melinta Therapeutics Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Melinta Therapeutics Recent Development Table Merck Company Details Table Merck Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Merck Recent Development Table Nabriva Therapeutics Company Details Table Nabriva Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Nabriva Therapeutics Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Nabriva Therapeutics Recent Development Table Paratek Pharmaceuticals Company Details Table Paratek Pharmaceuticals Revenue in Community Acquired Pneumonia (CAP) Business (2014-2019)(Million US$) Figure Paratek Pharmaceuticals Revenue Growth Rate in Community Acquired Pneumonia (CAP) Business (2014-2019) Table Paratek Pharmaceuticals Recent Development Table Global Community Acquired Pneumonia (CAP) Market Size by Regions (Million US$) 2019-2025 Figure Global Community Acquired Pneumonia (CAP) Market Size Share by Regions (2019-2025) Figure Global Community Acquired Pneumonia (CAP) Market Size Share by Regions in 2025 Figure United States Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Figure Europe Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Figure China Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Figure Japan Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Figure India Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Community Acquired Pneumonia (CAP) Market Size Forecast (2019-2025)(Million USD) Table Global Community Acquired Pneumonia (CAP) Market Size by Product (2019-2025) (Million US$) Figure Global Community Acquired Pneumonia (CAP) Market Size by Product (2019-2025) Figure Global Community Acquired Pneumonia (CAP) Market Size by Product in 2025 Table Global Community Acquired Pneumonia (CAP) Market Size by Application (2019-2025) (Million US$) Figure Global Community Acquired Pneumonia (CAP) Market Size by Application (2019-2025) Figure Global Community Acquired Pneumonia (CAP) Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Astrazeneca Bioaegis Therapeutics Biotest C10 Pharma Kyorin Pharmaceutical Melinta Therapeutics Merck Nabriva Therapeutics Paratek Pharmaceuticals